Literature DB >> 26307345

Overall Survival Is Impacted by Birthplace and Not Extent of Surgery in Asian Americans with Resectable Gastric Cancer.

Daniel D Kirchoff1, Gary B Deutsch1, Manabu Fujita1, David Y Lee1, Myung Shin Sim2, Ji Hey Lee1, Anton J Bilchik3,4.   

Abstract

Survival from gastric cancer in the USA still lags behind Asia. Genetic, environmental, and tumor biology differences, along with extent of surgery have been implicated. Our aim was to evaluate survival outcomes in Asian-American gastric cancer patients undergoing surgical resection by comparing place of birth and clinicopathologic characteristics (including evaluation of 15 lymph nodes).The Surveillance, Epidemiology, and End Results database was queried to identify patients treated surgically for gastric cancer with curative intent in the USA (2000-2010). US-born versus foreign-born Asian-American patients were analyzed for survival. Secondary comparison was made to non-Asian patients. Stage IV and non-surgical patients were excluded. Of 10,089 patients identified, 1467 patients were Asian: 271 were born in the USA, and 1196 were born outside the USA. Median survival was 32 months for non-Asians and 29 months for US-born Asians versus 61 months for Asian immigrants (p < 0.001). On multivariable analysis of overall survival in Asian patients, only US birthplace, older age, and higher stage yielded a significantly poorer outcome. Asian-American patients have a worse prognosis if born in the USA. Anatomic and surgical differences do not explain this disparity; environmental factors may be responsible.

Entities:  

Keywords:  Asian Americans; Ethnicity; Gastrectomy; Gastric cancer; Healthcare disparities

Mesh:

Year:  2015        PMID: 26307345     DOI: 10.1007/s11605-015-2919-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  34 in total

1.  7th edition of the AJCC cancer staging manual: stomach.

Authors:  Kay Washington
Journal:  Ann Surg Oncol       Date:  2010-12       Impact factor: 5.344

2.  Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Authors:  Chew-Wun Wu; Chao A Hsiung; Su-Shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Anna Fen-Yau Li; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  Lancet Oncol       Date:  2006-04       Impact factor: 41.316

3.  Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage.

Authors:  Roderich E Schwarz; David D Smith
Journal:  Ann Surg Oncol       Date:  2006-11-09       Impact factor: 5.344

4.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

Review 5.  Limitations of lymph node counts as a measure of therapy.

Authors:  Scott M Gilbert; Brent K Hollenbeck
Journal:  J Natl Compr Canc Netw       Date:  2009-01       Impact factor: 11.908

6.  Ethnic disparities in gastric cancer incidence and survival in the USA: an updated analysis of 1992-2009 SEER data.

Authors:  Felix H Lui; Bertrand Tuan; Sara L Swenson; Robert J Wong
Journal:  Dig Dis Sci       Date:  2014-07-17       Impact factor: 3.199

Review 7.  Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma.

Authors:  Kartar Singh; Uday C Ghoshal
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

8.  Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach.

Authors:  S Ohno; S Tomisaki; H Oiwa; Y Sakaguchi; Y Ichiyoshi; Y Maehara; K Sugimachi
Journal:  J Am Coll Surg       Date:  1995-05       Impact factor: 6.113

9.  Lymph node dissection in curative gastrectomy for advanced gastric cancer.

Authors:  Shigeyuki Tamura; Atsushi Takeno; Hirofumi Miki
Journal:  Int J Surg Oncol       Date:  2011-06-14

10.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Authors:  A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  6 in total

1.  Ethnicity-related differences in tumor immunity: a new possible explanation for gastric cancer prognostic variability?

Authors:  Daniele Marrelli; Karol Polom; Franco Roviello
Journal:  Transl Gastroenterol Hepatol       Date:  2016-03-16

2.  Endoscopic History and Provider Characteristics Influence Gastric Cancer Survival in Asian Americans.

Authors:  Christie Y Jeon; Yu-Chen Lin; Samuel J Klempner; Bechien U Wu; Sungjin Kim; Kevin M Waters; Robert W Haile
Journal:  Cancer Prev Res (Phila)       Date:  2020-06-19

3.  Stage-matched survival differences by ethnicity among gastric cancer patients of Asian ancestry treated in the United States.

Authors:  Ryan M Rhome; Meng Ru; Erin Moshier; Madhu Mazumdar; Michael H Buckstein
Journal:  J Surg Oncol       Date:  2019-01-29       Impact factor: 3.454

4.  Selective survival advantage associated with primary tumor resection for metastatic gastric cancer in a Western population.

Authors:  René Warschkow; Matthias Baechtold; Kenneth Leung; Bruno M Schmied; Daniel P Nussbaum; Beat Gloor; Dan G Blazer Iii; Mathias Worni
Journal:  Gastric Cancer       Date:  2017-06-23       Impact factor: 7.370

5.  High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability.

Authors:  Karol Polom; Daniele Marrelli; Valeria Pascale; Giandomenico Roviello; Costantino Voglino; Henry Rho; Carla Vindigni; Mario Marini; Raffaele Macchiarelli; Franco Roviello
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-20       Impact factor: 4.553

6.  Disaggregating Data on Pacific Islander Gastric Cancer Patients Reveals Survival Disparity.

Authors:  Gene T Yoshikawa; Nicholas Simon; Ryon K Nakasone; Jared D Acoba
Journal:  J Gastrointest Cancer       Date:  2021-01-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.